Literature DB >> 3280334

Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration.

K Marsh1, V M Marsh, J Brown, H C Whittle, B M Greenwood.   

Abstract

An in vitro model of Plasmodium falciparum-infected red blood cell sequestration which uses C32 amelanotic melanoma cells as targets has been used to examine the binding capacity of infected red blood cells from subjects with naturally acquired P. falciparum infections of varying severity. The binding of infected red blood cells (IRBCs) to melanoma cells was specific to cells containing mature parasites. Variations in target cell density and in conditions of growth had significant effects on binding. Binding was pH dependent, being maximum at a pH of 6.9. Using standardized conditions the binding capacity of individual isolates of P. falciparum could be measured with a high degree of reproducibility. Binding capacity of IRBCs from 51 subjects between the ages of 6 months and 15 years varied between 12 and 1254 IRBCs per 100 melanoma cells when RBC suspensions at a 1% parasitemia and 4% hematocrit were used. Variation in binding was not related to the level of peripheral parasitemia of the isolate or to differences in adaptation to culture conditions. The binding capacity of parasitized cells from subjects with cerebral malaria did not differ from that of IRBCs from subjects with less serious clinical manifestations.

Entities:  

Mesh:

Year:  1988        PMID: 3280334     DOI: 10.1016/0014-4894(88)90123-3

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  23 in total

1.  Rosette formation of Plasmodium falciparum-infected erythrocytes from patients with acute malaria.

Authors:  M Ho; T M Davis; K Silamut; D Bunnag; N J White
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 2.  Cerebral malaria.

Authors:  C R Newton; T T Hien; N White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

Review 3.  Host-parasite interaction and morbidity in malaria endemic areas.

Authors:  K Marsh; R W Snow
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

4.  Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells.

Authors:  C J McCormick; A Craig; D Roberts; C I Newbold; A R Berendt
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

5.  Cytoadherence and severe malaria.

Authors:  Alister G Craig; Mohd Fadzli Mustaffa Khairul; Pradeep R Patil
Journal:  Malays J Med Sci       Date:  2012-04

6.  Inhibition of Plasmodium falciparum field isolates-mediated endothelial cell apoptosis by Fasudil: therapeutic implications for severe malaria.

Authors:  Estelle S Zang-Edou; Ulrick Bisvigou; Zacharie Taoufiq; Faustin Lékoulou; Jean Bernard Lékana-Douki; Yves Traoré; Dominique Mazier; Fousseyni S Touré-Ndouo
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

7.  Parasite virulence and disease patterns in Plasmodium falciparum malaria.

Authors:  S Gupta; A V Hill; D Kwiatkowski; A M Greenwood; B M Greenwood; K P Day
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines.

Authors:  P Ringwald; F Peyron; J P Lepers; P Rabarison; C Rakotomalala; M Razanamparany; M Rabodonirina; J Roux; J Le Bras
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Plasmodium falciparum-infected erythrocytes do not adhere well to C32 melanoma cells or CD36 unless rosettes with uninfected erythrocytes are first disrupted.

Authors:  S M Handunnetti; T H Hasler; R J Howard
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 10.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.